MortonRL, O'HaganA, EidNS. The role of small airways in childhood asthma. Ped Allergy Immunol Pulmonol, 2012; 25:190–197.
2.
MammenJ, RheeH. Adolescent asthma self-management: a concept analysis and operational definition. Ped Allergy Immunol Pulmonol, 2012; 25:180–189.
3.
PavićI, HojsakI, Čepin-BogovićJ. Evidence-based management of chronic urticaria in children. Ped Allergy Immunol Pulmonol, 2012; 25:198–207.
4.
SalaKA, KaramessinisL, ZuckerAR, CarrollCL. Respiratory failure in children with status asthmaticus: a review of the VPS database. Ped Allergy Immunol Pulmonol, 2012; 25:226–230.
5.
AkinbamiLJ, MoormanJE, BaileyCet al.Trends in asthma prevalence, health care use, and mortality in the United States. 2001–2010NCHS data brief, no 94.Hyattsville, MD: National Center for Health Statistics, 2012. www.cdc.gov/nchs/data/databriefs/db94.pdf. 2012 November 6.
6.
MotomuraC, OdajimaH, HigashiNet al.Exercise-induced bronchoconstriction in children with asthma: is there an association with urinary leukotriene E4 or exhaled nitric oxide. Ped Allergy Immunol Pulmonol, 2012; 25:208–212.
7.
ElMallahMK, HendelesL. Delivery of medications by metered dose inhaler through a chamber/mask to young children with asthma. Ped Allergy Immunol Pulmonol, 2012; 25:236–240.
8.
Castro-EliasWA, SinghS, HiattPW, OermannCM, MooreRH. Efficacy of Ivacaftor in a child with Cystic Fibrosis, end-stage lung disease, and Cepacia Syndrome. Ped Allergy Immunol Pulmonol, 2012; 25:231–233.
9.
RobinsonWM. Commentary: some speculative thoughts on money and healthcare for Cystic Fibrosis. Ped Allergy Immunol Pulmonol, 2012; 25:234–235.
